Last reviewed: 6 November 2026. Prices verified against published clinic rates and Daman’s Growth Hormone indications guideline (February 2026 revision).
A pediatric endocrinologist consultation in Dubai costs AED 275 to AED 800. Growth hormone therapy runs AED 2,500 to AED 10,000 a month on top of that. Insurance pays only if your child clears a stimulation test, a bone-age X-ray and a written pre-authorization. Miss one step and you are funding AED 60,000 a year yourself.
That last figure is the one nobody mentions at the first appointment.
What this costs, line by line
- Specialist consult: AED 275 at Aster, AED 800 at Clemenceau. Most families pay AED 450–600.
- Follow-up: AED 200–660, and you will have one every three months during treatment.
- Diagnostic workup: AED 1,500–4,000 before anyone writes a prescription.
- Growth hormone itself: AED 2,500–10,000 per month, weight-based.
- Monitoring bloods: AED 150–500 per panel, quarterly.
- Total year one, self-paid: roughly AED 45,000–110,000.
Why a GP is the wrong first stop
Short stature has maybe a dozen causes and only some of them respond to growth hormone. A GP can plot your child on a growth chart. A pediatric endocrinologist decides whether that curve means constitutional delay (they catch up on their own, spend nothing), familial short stature (they will be a normal adult height, spend nothing), true growth hormone deficiency (treat), hypothyroidism (a daily tablet, a few hundred dirhams a year), coeliac disease (a diet change), Turner syndrome in a girl, or something pituitary that needs an MRI.
I watched a family in Al Barsha pay for eleven months of growth hormone out of pocket before anyone checked the thyroid. Untreated hypothyroidism stunts growth and mimics deficiency. The fix was levothyroxine.
Dubai’s insurers know this pattern. Daman’s guideline states flatly that growth hormone “should not be prescribed by a General Practitioner.” If a GP hands you an HGH prescription, the claim dies at adjudication and the pharmacy has already been paid.
Book the specialist first. AED 275 to AED 800 is the cheapest step in the entire pathway.
Pediatric endocrinologist consultation prices in Dubai (2026)
These are published or quoted initial-consultation rates as of November 2026. Follow-ups typically run 30–50% cheaper.
| Provider | Location | Initial consult (AED) | Notes |
|---|---|---|---|
| Aster Clinic / Hospital — Dr. Patanjali Panduranga, Dr. Asif Majid Khan, Dr. Arvind Gaddameedi, Dr. Prakash Pania | Al Qusais, Al Warqa, Bur Dubai, JLT | 275 | Cheapest private rate in the emirate. High volume, so the appointment is shorter. |
| Polyclinic — Dr. Elena Mironova, Dr. Maria Sedova, Dr. Abdullah Azad (390); most consultants 590 | Jumeirah Road 632 | 390–590 | Several profiles admit from age 0; others from 12 or 16. Check before booking. |
| Canadian Specialist Hospital — Dr. Ahmed El Awad | Deira | 525 | Adult and paediatric |
| Fakeeh University Hospital — Dr. Salwa Nassif Azar | Dubai Silicon Oasis | 585 | Newer campus, digital records |
| Medcare Hospital Al Safa — Dr. Yasmeen Ajaz | Al Safa / Jumeirah | 610 | Paediatric endocrinology also at Medcare Women & Children, Sheikh Zayed Road |
| Clemenceau Medical Center — Dr. Ghada Ballane | Dubai Healthcare City Phase 2 | 800 | Top of the private range |
| Dubai Health / Al Jalila Children’s Specialty Hospital — Dr. Manal Mustafa, Dr. Layla Almarzooqi, Dr. Maysa Saleh | Al Jaddaf | Public schedule (AED 100–300 band by doctor grade) | Book on 800 60. Waiting list is the trade-off. |
Booking aggregators quote “AED 0–750” for endocrinologists in Dubai because they blend free tele-triage, adult specialists and in-person rates into one number. Filter for paediatric endocrinology. An adult endocrinologist seeing a seven-year-old is a common and expensive mistake.
Two traps I keep seeing on booking calls:
- Age cut-offs. Polyclinic lists “children admission from age 12” or “from 16” on several endocrinology profiles. Put a five-year-old into that slot and the fee is spent before the doctor walks in.
- Referral paperwork. Several Daman and AXA networks want a pediatrician referral on file before the specialist visit bills as covered. Get it printed from your GP clinic. Verbal referrals do not survive adjudication.
The workup: what happens before anyone prescribes HGH
Expect two to four visits across three to six weeks. Here is the standard panel and what each piece costs in Dubai.
| Test | Why it is done | Cost (AED) |
|---|---|---|
| Auxology and growth charts | Height SD score, velocity in cm/year, mid-parental height, projected adult height | Included in the consult |
| Bone age X-ray (left hand and wrist) | How much growing time is left. Compulsory evidence for insurers above age 12. | 150–450 * |
| IGF-1 and IGFBP-3 | Deficiency screen, read against age and sex reference ranges | 250–600 * |
| Thyroid function (TSH, free T4) | Hypothyroidism is the great mimic | 150–350 * |
| Coeliac serology (tTG-IgA plus total IgA) | At Al Jalila, 2.7% of screened children had coeliac disease; 30.4% of those also had type 1 diabetes | 200–400 * |
| Karyotype in girls; SHOX / genetic panels | Turner syndrome presents as isolated short stature in a large share of cases | 1,200–3,000 * |
| Growth hormone stimulation test (arginine, glucagon or insulin) | The definitive test. A peak below 5 ng/mL is Daman’s threshold. | 1,500–3,000 * (day-case included) |
| Pituitary MRI, if deficiency is confirmed | Rules out structural and tumour causes | 900–3,500 |
* Estimates. Clinics do not publish stimulation-test or bone-age pricing. The ranges are derived from per-assay lab rates (DCDC publishes AED 150–500 per blood test) and Dubai imaging rate cards (MRI AED 900–7,980). Ask for a written quote before you consent to anything, and ask whether the day-case facility fee is inside or outside the assay price. It usually is not.
Growth hormone therapy cost in Dubai (2026)
Dosing is weight-based, so a 20 kg child and a 45 kg adolescent are on different planets financially. Brand matters too: daily somatropin pens versus weekly somatrogon.
| Item | Dubai cost (AED) | Notes |
|---|---|---|
| Somatropin, daily injections, smaller child | 2,500–4,000 / month | Kamura’s UAE cost guide puts the national band at 2,500–5,000 |
| Somatropin, daily injections, adolescent dose | 5,000–10,000+ / month | Novomed quotes AED 2,000–10,000+ across indications, in Dubai, Abu Dhabi and Al Ain |
| Somatrogon, weekly injection | Quote only | Licensed from age 3 for growth hormone deficiency; Daman lists it as a covered long-acting product |
| Mecasermin (severe primary IGF-1 deficiency) | Quote only | Only for IGF-1 deficiency or neutralising antibodies to GH — not a first-line drug |
| Quarterly monitoring: bloods plus follow-up visit | 600–1,300 / quarter | IGF-1, glucose, thyroid, weight, height |
| Year one, self-paid total | 45,000–110,000 | Workup, drug and monitoring combined |
| Usual duration | Until growth plates close | Often 3–7 years. Budget for the whole course, not one year. |
Not one Dubai clinic publishes a fixed package price. Every page says “varies by dose,” which is technically honest and practically useless. Get the monthly figure in writing, and ask explicitly what happens to the price when your child gains 10 kg — because it goes up, and mid-course repricing is where families get caught.
Insurance: the Daman criteria, in plain English
Daman’s Growth Hormone indications guideline (February 2026 revision) is the strictest version of this rule set in the UAE, and the most useful document in the whole journey, because other insurers’ criteria look similar. Print it out. Take it to the appointment.
For a child under 18, coverage requires a confirmed diagnosis plus evidence:
- Growth hormone deficiency, hypopituitarism, post-procedural or drug-induced hypopituitarism: a stimulation test using arginine, glucagon or insulin with a subnormal peak below 5 ng/mL (or below the testing lab’s reference), or IGF-1 and IGFBP-3 both below the range for age and sex.
- GHD with neonatal hypoglycaemia: serum growth hormone below 5 ng/mL.
- Born small for gestational age with no catch-up by age 2–4: over 2 years old, height at least 2 SD below the mean for age and sex, open growth plates on X-ray (mandatory above age 12), bone age below chronological age, or projected adult height more than 8.5 cm below mid-parental height.
- Syndromic short stature: Prader-Willi, Turner, Noonan, SHOX deficiency, Laron-type, Léri-Weill, chronic renal insufficiency, short bowel syndrome.
- HIV wasting or cachexia: documented unexplained weight loss above 10% of baseline while currently on antiretroviral treatment.
The red flags Daman spells out:
- Growth hormone medications always require authorization.
- They should not be prescribed by a general practitioner.
- A provider-completed authorization request form must accompany the claim, with lab results and the growth chart attached.
- Not covered on Visitor plans. Not covered on any plan unless medically necessary.
- Claims get rejected if the clinic fails to submit the clinical history on request.
And the stop rules. Funding ends at whichever comes first: growth velocity below 2 cm/year, complete epiphyseal fusion, or bone age showing growth is finished — under 14 in girls, under 16 in boys.
Idiopathic short stature — a healthy child who is simply small, with no deficiency — is the grey zone. Daman’s diagnosis table lists it, but the published requirements column is blank. In practice authorization hinges on the same auxological evidence, and plenty of families are declined. Budget as though you are paying, then appeal with the growth chart and the projected adult height calculation.
One more thing worth knowing: Daman’s definition of short stature is height 2 SD or more below the mean for sex and age, which is below the 2.3rd percentile on WHO charts or the 5th percentile on CDC charts. If your paediatrician says “low-normal,” ask which percentile and which chart. The difference decides whether an insurer engages at all.
Who should not get growth hormone
This is a prescription hormone, not a supplement and not a height cosmetic. The somatropin label and UAE clinic protocols both list hard stops:
- Closed growth plates. Kamura states it plainly: contraindicated for growth purposes once the epiphyses have fused. After that, no height gain is possible at any dose.
- Active malignancy, or a brain tumour that has not been treated and stabilised.
- Acute critical illness — recovery after open-heart or abdominal surgery, or respiratory failure. Post-operative patients were harmed in the trials that produced this boxed warning.
- Proliferative diabetic retinopathy.
- Untreated hypothyroidism. Correct the thyroid first. Growth often restarts without HGH at all.
- Active serious infection. Postpone and reassess.
Side effects to raise at every single visit: scoliosis progressing during fast growth, hip or knee pain suggesting slipped capital femoral epiphysis, swelling and tingling from fluid retention, raised intracranial pressure (morning headache with vomiting), and worsening insulin resistance. Any new limp is an urgent review, not a wait-and-see.
What the evidence actually supports
Two different questions, two different answers. Confusing them is how families end up spending six figures.
Confirmed growth hormone deficiency: treatment is not controversial. Children who start early and stay on it reach normal or near-normal adult height, and the first year usually shows the fastest catch-up velocity. This is precisely why insurers fund it.
Idiopathic short stature, no deficiency: the gain is real but modest — roughly 3–7 cm of final adult height across trials, bought with years of daily injections. Some Dubai clinics say this outright when you push them. It is a genuinely hard call, and it is a harder call at AED 60,000 a year than in markets where the same drug costs a fraction of that.
Watch the claim you are sold. Observational data on adult height is not a trial result. And a marketing page promising to “normalize growth velocity” is describing the deficient population, not your healthy short child. Ask the doctor, in the room: is my child in the trial group or the control group?
If you cannot fund it: the public and charity routes
Dubai has more scaffolding here than most parents realise, and none of it is advertised at the clinic desk.
- Al Jalila Children’s Specialty Hospital (Dubai Health, Al Jaddaf) runs a paediatric endocrinology service — consultants include Dr. Manal Mustafa, Dr. Layla Almarzooqi and Dr. Maysa Saleh. Book through Dubai Health on 800 60.
- Al Jalila Foundation’s A’awen programme funds advanced intervention for children whose treatment costs exceed family means. It runs alongside the Clinic of Hope, a charitable initiative held at Al Jalila that has treated more than 2,100 children of various nationalities since March 2024 across 15+ specialties including endocrinology.
- Check the enhanced tier before you self-pay a single month. Denials on a basic plan are often a limit problem, not a criteria problem. Ask HR what the company’s enhanced specialty-drug annual cap is.
- Emirates nationals and some GCC residents route through government coverage entirely — Daman’s guideline notes nationals are exempt from several related lab fees. Confirm eligibility before buying anything privately.
When to stop waiting: the diabetes red flag
Short stature gets the attention. Type 1 diabetes in UAE children is the quieter emergency, and a paediatric endocrinologist is the doctor who catches it early.
The UAE carries an estimated 9,939 children under 20 with type 1 diabetes, out of roughly 79,000 cases nationally. In a 243-child cohort at a tertiary hospital in the Eastern Region, mean HbA1c was 8.64% and 38.8% of children presented in diabetic ketoacidosis. At Al Jalila, of 346 children with type 1 diabetes followed between 2017 and 2023, 75.9% had uncontrolled HbA1c and 55.1% were underweight for their age. A national survey of 6,365 adolescents across 151 schools put self-reported diabetes prevalence at 0.9% overall — 1.5% in boys, 0.5% in girls.
Translation for parents: excessive thirst and urination, weight loss despite eating well, bedwetting returning in a previously dry child, fruity breath, or a child who is listless and vomiting after weeks of “just a virus.” That is an emergency department, same hour — not an appointment next Thursday. DKA at presentation is the biggest preventable harm in paediatric diabetes, and in this country it is roughly a third of all first presentations.
Frequently asked questions
How much does a pediatric endocrinologist cost in Dubai?
Initial consultations run AED 275 to AED 800 in the private sector. Aster is the cheapest at AED 275 across Al Qusais, Al Warqa, Bur Dubai and JLT; Clemenceau Medical Center is the most expensive at AED 800. Most private hospitals sit between AED 500 and AED 650. Follow-ups cost AED 200–660. Dubai Health’s Al Jalila Children’s Hospital bills on a public schedule in the AED 100–300 band by doctor grade, bookable on 800 60.
Does insurance cover growth hormone therapy for children in Dubai?
Only when medically necessary and pre-authorized. Daman requires a stimulation test peak below 5 ng/mL, or IGF-1 and IGFBP-3 both below the age and sex reference range, plus a completed authorization form with labs and growth charts attached. Coverage extends to defined syndromes — Turner, Prader-Willi, Noonan, SHOX deficiency, small-for-gestational-age with no catch-up. It is never covered on Visitor plans, and never on a prescription written by a general practitioner.
How much is a growth hormone injection per month in Dubai?
AED 2,500 to AED 4,000 a month for a smaller child on daily somatropin, rising to AED 5,000–10,000+ for an adolescent dose. Novomed publishes a range of AED 2,000 to AED 10,000+ per month across indications, and Kamura’s UAE guide quotes AED 2,500–5,000. Doses are recalculated as the child gains weight, so the monthly cost climbs through treatment. Weekly somatrogon is priced on quote only.
Is growth hormone covered for idiopathic short stature in the UAE?
Treat it as unlikely. Daman’s diagnosis table lists idiopathic short stature, but the published requirement column is blank, and authorization in practice demands the same auxological evidence as the other indications — height 2 SD below the mean, open growth plates, and projected adult height more than 8.5 cm below mid-parental height. Many families are declined at first submission. Budget as self-pay, then appeal with the growth chart and the mid-parental calculation attached.
When should I worry about my child’s height?
Three triggers. Growth velocity below 5 cm per year during childhood, outside of normal puberty timing. Crossing downward through two or more percentile lines on a growth chart. Height 2 SD or more below the mean for age and sex — below the 2.3rd percentile on WHO charts or the 5th on CDC charts. Also book if there is no pubertal growth spurt by the expected age, or if a girl under 12 has short stature with no other explanation, because that is how Turner syndrome is usually found.
Next steps
- This week: pull your child’s last three measured heights from any source — clinic, school screening, or your own growth record. Three points make a velocity. One point makes nothing, and velocity is the number the insurer asks for first.
- Book a paediatric (not adult) endocrinologist. Aster at AED 275 if price leads; Al Jalila via 800 60 if you want the public route. Confirm on the phone that the doctor admits your child’s age.
- Get the pre-auth criteria in writing from your insurer before the second visit, and hand the clinic the exact ICD-10 wording they request. Coding vagueness is a top rejection reason.
- Demand a written monthly drug quote that states the dose-recalculation rule as your child gains weight.
- Do not start growth hormone on a GP prescription. It will be denied, and the pharmacy will not refund you.
If your child also needs developmental, speech or hearing assessment while you are inside the system, our paediatric audiologist cost guide and early intervention therapy guide cover the same insurance mechanics from a different door. Start with the hearing test if speech is involved — untreated hearing loss masquerades as everything else.
Disclosure
ikeyam.net takes no payment from the clinics named here. Prices are published or quoted rates verified in November 2026. Some outbound links are affiliate links; if you book through them we may earn a small commission at no extra cost to you.
Medical disclaimer
This article is for informational purposes only. Consult a DHA-licensed pediatric endocrinologist for medical advice. Growth hormone is a prescription medicine with contraindications and monitored side effects. Dosing, coverage criteria and pricing change — verify with your insurer and provider before starting or continuing treatment.